Loading…

Nonsteroidal cardiotonics. 1. 2-Pyridyl-6,7-dihydro-3H,5H-pyrrolo[2,3-f]benzimidazol-6-ones, a novel class of cardiotonic agents

A series of substituted 2-pyridyl-6,7-dihydro-3H,5H-pyrrolo[2,3-f]benzimidazol-6-ones 1-24 were synthesized and evaluated for positive inotropic activity. In rats, cats, and dogs most of these tricyclic heterocycles produced a dose-related increase in myocardial contractility with little effect on h...

Full description

Saved in:
Bibliographic Details
Published in:Journal of medicinal chemistry 1987-08, Vol.30 (8), p.1279-1287
Main Authors: Mertens, A, Mueller-Beckmann, B, Kampe, W, Hoelck, J. P, Von der Saal, W
Format: Article
Language:English
Subjects:
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-a354t-12e5bab0853d30a437c8e6b347fbe1f5daee31b6e3e05b3a8a8ba1a8b74fe5e23
cites
container_end_page 1287
container_issue 8
container_start_page 1279
container_title Journal of medicinal chemistry
container_volume 30
creator Mertens, A
Mueller-Beckmann, B
Kampe, W
Hoelck, J. P
Von der Saal, W
description A series of substituted 2-pyridyl-6,7-dihydro-3H,5H-pyrrolo[2,3-f]benzimidazol-6-ones 1-24 were synthesized and evaluated for positive inotropic activity. In rats, cats, and dogs most of these tricyclic heterocycles produced a dose-related increase in myocardial contractility with little effect on heart rate and blood pressure. The increase in contractility was not mediated via stimulation of beta-adrenergic receptors. Compound 1 (BM 14.478) was more potent than milrinone (25) and enoximone when administered intravenously to rats, cats, and dogs. After oral administration of 1 mg/kg, compound 1, milrinone, and pimobendan were equipotent. However, only 1 and pimobendan were still active after 6 h. The structural requirements necessary for optimal cardiotonic activity within this novel class of heterocycles were investigated.
doi_str_mv 10.1021/jm00391a004
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_77634099</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>77634099</sourcerecordid><originalsourceid>FETCH-LOGICAL-a354t-12e5bab0853d30a437c8e6b347fbe1f5daee31b6e3e05b3a8a8ba1a8b74fe5e23</originalsourceid><addsrcrecordid>eNptkE1rFEEURQsxxDG6ci30ShdOjfXdPcsY1AkEDWQUUaR41f1aa-zuGqt6xM4qPz0lM4Qs3Ly3uId74RDyjLMFZ4K_3vSMySUHxtQDMuNaMKoqph6SGWNCUGGEfEQep7RhmeNCHpNjabgwFZ-Rmw9hSCPG4Bvoihpi48MYBl-nRcEXhaCXU_TN1FEzL2njf05NDFSu5npFt1OMoQvfxFzS9rvD4dr3ueU6ZJiGAdO8gGIIfzD3dpBSEdr7AwX8wGFMT8hRC13Cp4d_Qj69e7s-W9GLj-_Pz04vKEitRsoFageOVVo2koGSZV2hcVKVrUPe6gYQJXcGJTLtJFRQOeD5lKpFjUKekBf73m0Mv3eYRtv7VGPXwYBhl2xZGqnYcpnBV3uwjiGliK3dRt9DnCxn9p9ve893pp8faneux-aOPQjOOd3nPlv-exdD_GVNKUtt15dX9o368vlKmK92nfmXex7qZDdhF4cs5b_Ltyprlr4</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>77634099</pqid></control><display><type>article</type><title>Nonsteroidal cardiotonics. 1. 2-Pyridyl-6,7-dihydro-3H,5H-pyrrolo[2,3-f]benzimidazol-6-ones, a novel class of cardiotonic agents</title><source>ACS CRKN Legacy Archives</source><creator>Mertens, A ; Mueller-Beckmann, B ; Kampe, W ; Hoelck, J. P ; Von der Saal, W</creator><creatorcontrib>Mertens, A ; Mueller-Beckmann, B ; Kampe, W ; Hoelck, J. P ; Von der Saal, W</creatorcontrib><description>A series of substituted 2-pyridyl-6,7-dihydro-3H,5H-pyrrolo[2,3-f]benzimidazol-6-ones 1-24 were synthesized and evaluated for positive inotropic activity. In rats, cats, and dogs most of these tricyclic heterocycles produced a dose-related increase in myocardial contractility with little effect on heart rate and blood pressure. The increase in contractility was not mediated via stimulation of beta-adrenergic receptors. Compound 1 (BM 14.478) was more potent than milrinone (25) and enoximone when administered intravenously to rats, cats, and dogs. After oral administration of 1 mg/kg, compound 1, milrinone, and pimobendan were equipotent. However, only 1 and pimobendan were still active after 6 h. The structural requirements necessary for optimal cardiotonic activity within this novel class of heterocycles were investigated.</description><identifier>ISSN: 0022-2623</identifier><identifier>EISSN: 1520-4804</identifier><identifier>DOI: 10.1021/jm00391a004</identifier><identifier>PMID: 3612681</identifier><language>eng</language><publisher>United States: American Chemical Society</publisher><subject>Animals ; Benzimidazoles - chemical synthesis ; Benzimidazoles - pharmacology ; Blood Pressure - drug effects ; Cardiotonic Agents ; Cats ; Chemical Phenomena ; Chemistry ; Dogs ; Dose-Response Relationship, Drug ; Female ; Heart Rate - drug effects ; Male ; Myocardial Contraction - drug effects ; Pyridines - chemical synthesis ; Pyridines - pharmacology ; Pyrroles - chemical synthesis ; Pyrroles - pharmacology ; Rats ; Stimulation, Chemical ; Structure-Activity Relationship</subject><ispartof>Journal of medicinal chemistry, 1987-08, Vol.30 (8), p.1279-1287</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-a354t-12e5bab0853d30a437c8e6b347fbe1f5daee31b6e3e05b3a8a8ba1a8b74fe5e23</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://pubs.acs.org/doi/pdf/10.1021/jm00391a004$$EPDF$$P50$$Gacs$$H</linktopdf><linktohtml>$$Uhttps://pubs.acs.org/doi/10.1021/jm00391a004$$EHTML$$P50$$Gacs$$H</linktohtml><link.rule.ids>314,780,784,27063,27923,27924,56765,56815</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/3612681$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Mertens, A</creatorcontrib><creatorcontrib>Mueller-Beckmann, B</creatorcontrib><creatorcontrib>Kampe, W</creatorcontrib><creatorcontrib>Hoelck, J. P</creatorcontrib><creatorcontrib>Von der Saal, W</creatorcontrib><title>Nonsteroidal cardiotonics. 1. 2-Pyridyl-6,7-dihydro-3H,5H-pyrrolo[2,3-f]benzimidazol-6-ones, a novel class of cardiotonic agents</title><title>Journal of medicinal chemistry</title><addtitle>J. Med. Chem</addtitle><description>A series of substituted 2-pyridyl-6,7-dihydro-3H,5H-pyrrolo[2,3-f]benzimidazol-6-ones 1-24 were synthesized and evaluated for positive inotropic activity. In rats, cats, and dogs most of these tricyclic heterocycles produced a dose-related increase in myocardial contractility with little effect on heart rate and blood pressure. The increase in contractility was not mediated via stimulation of beta-adrenergic receptors. Compound 1 (BM 14.478) was more potent than milrinone (25) and enoximone when administered intravenously to rats, cats, and dogs. After oral administration of 1 mg/kg, compound 1, milrinone, and pimobendan were equipotent. However, only 1 and pimobendan were still active after 6 h. The structural requirements necessary for optimal cardiotonic activity within this novel class of heterocycles were investigated.</description><subject>Animals</subject><subject>Benzimidazoles - chemical synthesis</subject><subject>Benzimidazoles - pharmacology</subject><subject>Blood Pressure - drug effects</subject><subject>Cardiotonic Agents</subject><subject>Cats</subject><subject>Chemical Phenomena</subject><subject>Chemistry</subject><subject>Dogs</subject><subject>Dose-Response Relationship, Drug</subject><subject>Female</subject><subject>Heart Rate - drug effects</subject><subject>Male</subject><subject>Myocardial Contraction - drug effects</subject><subject>Pyridines - chemical synthesis</subject><subject>Pyridines - pharmacology</subject><subject>Pyrroles - chemical synthesis</subject><subject>Pyrroles - pharmacology</subject><subject>Rats</subject><subject>Stimulation, Chemical</subject><subject>Structure-Activity Relationship</subject><issn>0022-2623</issn><issn>1520-4804</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1987</creationdate><recordtype>article</recordtype><recordid>eNptkE1rFEEURQsxxDG6ci30ShdOjfXdPcsY1AkEDWQUUaR41f1aa-zuGqt6xM4qPz0lM4Qs3Ly3uId74RDyjLMFZ4K_3vSMySUHxtQDMuNaMKoqph6SGWNCUGGEfEQep7RhmeNCHpNjabgwFZ-Rmw9hSCPG4Bvoihpi48MYBl-nRcEXhaCXU_TN1FEzL2njf05NDFSu5npFt1OMoQvfxFzS9rvD4dr3ueU6ZJiGAdO8gGIIfzD3dpBSEdr7AwX8wGFMT8hRC13Cp4d_Qj69e7s-W9GLj-_Pz04vKEitRsoFageOVVo2koGSZV2hcVKVrUPe6gYQJXcGJTLtJFRQOeD5lKpFjUKekBf73m0Mv3eYRtv7VGPXwYBhl2xZGqnYcpnBV3uwjiGliK3dRt9DnCxn9p9ve893pp8faneux-aOPQjOOd3nPlv-exdD_GVNKUtt15dX9o368vlKmK92nfmXex7qZDdhF4cs5b_Ltyprlr4</recordid><startdate>19870801</startdate><enddate>19870801</enddate><creator>Mertens, A</creator><creator>Mueller-Beckmann, B</creator><creator>Kampe, W</creator><creator>Hoelck, J. P</creator><creator>Von der Saal, W</creator><general>American Chemical Society</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>19870801</creationdate><title>Nonsteroidal cardiotonics. 1. 2-Pyridyl-6,7-dihydro-3H,5H-pyrrolo[2,3-f]benzimidazol-6-ones, a novel class of cardiotonic agents</title><author>Mertens, A ; Mueller-Beckmann, B ; Kampe, W ; Hoelck, J. P ; Von der Saal, W</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a354t-12e5bab0853d30a437c8e6b347fbe1f5daee31b6e3e05b3a8a8ba1a8b74fe5e23</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1987</creationdate><topic>Animals</topic><topic>Benzimidazoles - chemical synthesis</topic><topic>Benzimidazoles - pharmacology</topic><topic>Blood Pressure - drug effects</topic><topic>Cardiotonic Agents</topic><topic>Cats</topic><topic>Chemical Phenomena</topic><topic>Chemistry</topic><topic>Dogs</topic><topic>Dose-Response Relationship, Drug</topic><topic>Female</topic><topic>Heart Rate - drug effects</topic><topic>Male</topic><topic>Myocardial Contraction - drug effects</topic><topic>Pyridines - chemical synthesis</topic><topic>Pyridines - pharmacology</topic><topic>Pyrroles - chemical synthesis</topic><topic>Pyrroles - pharmacology</topic><topic>Rats</topic><topic>Stimulation, Chemical</topic><topic>Structure-Activity Relationship</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Mertens, A</creatorcontrib><creatorcontrib>Mueller-Beckmann, B</creatorcontrib><creatorcontrib>Kampe, W</creatorcontrib><creatorcontrib>Hoelck, J. P</creatorcontrib><creatorcontrib>Von der Saal, W</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of medicinal chemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Mertens, A</au><au>Mueller-Beckmann, B</au><au>Kampe, W</au><au>Hoelck, J. P</au><au>Von der Saal, W</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Nonsteroidal cardiotonics. 1. 2-Pyridyl-6,7-dihydro-3H,5H-pyrrolo[2,3-f]benzimidazol-6-ones, a novel class of cardiotonic agents</atitle><jtitle>Journal of medicinal chemistry</jtitle><addtitle>J. Med. Chem</addtitle><date>1987-08-01</date><risdate>1987</risdate><volume>30</volume><issue>8</issue><spage>1279</spage><epage>1287</epage><pages>1279-1287</pages><issn>0022-2623</issn><eissn>1520-4804</eissn><abstract>A series of substituted 2-pyridyl-6,7-dihydro-3H,5H-pyrrolo[2,3-f]benzimidazol-6-ones 1-24 were synthesized and evaluated for positive inotropic activity. In rats, cats, and dogs most of these tricyclic heterocycles produced a dose-related increase in myocardial contractility with little effect on heart rate and blood pressure. The increase in contractility was not mediated via stimulation of beta-adrenergic receptors. Compound 1 (BM 14.478) was more potent than milrinone (25) and enoximone when administered intravenously to rats, cats, and dogs. After oral administration of 1 mg/kg, compound 1, milrinone, and pimobendan were equipotent. However, only 1 and pimobendan were still active after 6 h. The structural requirements necessary for optimal cardiotonic activity within this novel class of heterocycles were investigated.</abstract><cop>United States</cop><pub>American Chemical Society</pub><pmid>3612681</pmid><doi>10.1021/jm00391a004</doi><tpages>9</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0022-2623
ispartof Journal of medicinal chemistry, 1987-08, Vol.30 (8), p.1279-1287
issn 0022-2623
1520-4804
language eng
recordid cdi_proquest_miscellaneous_77634099
source ACS CRKN Legacy Archives
subjects Animals
Benzimidazoles - chemical synthesis
Benzimidazoles - pharmacology
Blood Pressure - drug effects
Cardiotonic Agents
Cats
Chemical Phenomena
Chemistry
Dogs
Dose-Response Relationship, Drug
Female
Heart Rate - drug effects
Male
Myocardial Contraction - drug effects
Pyridines - chemical synthesis
Pyridines - pharmacology
Pyrroles - chemical synthesis
Pyrroles - pharmacology
Rats
Stimulation, Chemical
Structure-Activity Relationship
title Nonsteroidal cardiotonics. 1. 2-Pyridyl-6,7-dihydro-3H,5H-pyrrolo[2,3-f]benzimidazol-6-ones, a novel class of cardiotonic agents
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-10T16%3A45%3A16IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Nonsteroidal%20cardiotonics.%201.%202-Pyridyl-6,7-dihydro-3H,5H-pyrrolo%5B2,3-f%5Dbenzimidazol-6-ones,%20a%20novel%20class%20of%20cardiotonic%20agents&rft.jtitle=Journal%20of%20medicinal%20chemistry&rft.au=Mertens,%20A&rft.date=1987-08-01&rft.volume=30&rft.issue=8&rft.spage=1279&rft.epage=1287&rft.pages=1279-1287&rft.issn=0022-2623&rft.eissn=1520-4804&rft_id=info:doi/10.1021/jm00391a004&rft_dat=%3Cproquest_cross%3E77634099%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-a354t-12e5bab0853d30a437c8e6b347fbe1f5daee31b6e3e05b3a8a8ba1a8b74fe5e23%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=77634099&rft_id=info:pmid/3612681&rfr_iscdi=true